ask="N/A"
ask_size="N/A"
average_daily_volume="498079"
bid="N/A"
bid_size="N/A"
book_value="18.34"
change="+0.59"
change_from_200_day_moving_average="3.02"
change_from_50_day_moving_average="3.89"
change_from_52_week_high="-6.60"
change_From_52_week_low="16.88"
change_in_percent="+0.72%"
close="82.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="2.96"
ebitda="360.06M"
eps_estimate_current_year="4.47"
eps_estimate_next_quarter="1.14"
eps_estimate_next_year="5.05"
ex_dividend_date="N/A"
float_shares="46450000"
high="82.61"
high_52_weeks="89.18"
last_trade_date="2/7/2017"
last_trade_price="82.58"
last_trade_size="17324"
last_trade_time="4:02pm"
low="81.46"
low_52_weeks="65.70"
market_capitalization="3.91B"
moving_average_200_day="79.56"
moving_average_50_day="78.69"
name="Charles River Laboratories Inte"
notes="N/A"
one_year_target_price="86.04"
open="82.39"
pe_ratio="27.91"
peg_ratio="1.45"
percent_change_from_200_day_moving_average="+3.80%"
percent_change_from_50_day_moving_average="+4.94%"
percent_change_from_52_week_high="-7.40%"
percent_change_from_52_week_low="+25.69%"
previous_close="81.99"
price_eps_estimate_current_year="18.47"
price_eps_Estimate_next_year="16.35"
price_per_book="4.47"
price_per_sales="2.47"
revenue="1.57B"
shares_outstanding="47328000"
short_ratio="4.31"
stock_exchange="NYQ"
symbol="CRL"
volume="289566"
weeks_range_52="65.70 - 89.18"
